Physician
Family Medicine of White Hall, P.A.
Family Medicine of White Hall, P.A. was paid $869K by Medicaid between Jan 2018 and Nov 2024, across 47 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 39% of everything it billed.
33Billing provider infoFAMILY MEDICINE OF WHITE HALL, P.A.
WHITE HALL, AR 71602
WHITE HALL, AR 71602
33aNPI1972730919assigned 06/17/2009
33bProvider typeFamily Medicine Physician
28Total paid$869K
24GClaims27,361
24DCodes billed47
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Family Medicine Physician providers in Arkansas
Rank by total paid#20 of 437
Median peer was paid$70K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,712 | $215K | |
| 2019 | 9,977 | $320K | |
| 2020 | 7,272 | $263K | |
| 2021 | 841 | $23K | |
| 2022 | 835 | $28K | |
| 2023 | 420 | $14K | |
| 2024incomplete | 304 | $5K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 39% | 11,270 | 9,294 | $341K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 27% | 2,198 | 2,011 | $236K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 10% | 2,002 | 1,840 | $91K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.9% | 1,865 | 1,638 | $78K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 1.8% | 322 | 305 | $16K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.7% | 358 | 319 | $15K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.3% | 237 | 212 | $12K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.2% | 314 | 282 | $11K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.1% | 242 | 226 | $10K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 214 | 193 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 621 | 305 | $7K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 224 | 165 | $6K |
35 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 475 | $5K |
| 90686 | <1% | 512 | $4K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 575 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 218 | $3K |
| 90670 | <1% | 244 | $2K | |
| 99490 | Ccm add 20min | <1% | 354 | $2K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 785 | $2K |
| 90647 | <1% | 207 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 919 | $2K |
| 81003 | <1% | 678 | $1K | |
| 90633 | <1% | 158 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 80 | $992.28 |
| 90723 | <1% | 110 | $936.88 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 34 | $920.75 |
| 84480 | <1% | 81 | $887.18 | |
| 90734 | <1% | 104 | $860.40 | |
| 80061 | Lipid panel | <1% | 119 | $824.97 |
| T1502 | Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit | <1% | 608 | $795.20 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 460 | $768.32 |
| 80053 | Comprehensive metabolic panel | <1% | 72 | $606.02 |
| 84439 | <1% | 81 | $564.92 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 59 | $564.05 |
| 90649 | <1% | 55 | $439.76 | |
| 90685 | <1% | 47 | $325.04 | |
| 90700 | <1% | 31 | $267.68 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 12 | $233.70 |
| 90710 | <1% | 25 | $210.32 | |
| 82962 | <1% | 121 | $201.88 | |
| G0008 | Administration of influenza virus vaccine | <1% | 40 | $185.40 |
| 90715 | <1% | 16 | $133.84 | |
| 90713 | <1% | 12 | $114.72 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 15 | $112.00 |
| 3078F | 0% | 86 | $0.00 | |
| 3074F | 0% | 87 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialREECE, TIMMOTHY (OWNER)